Knapp LR, Fischer KS, Sosat J, Villena-Ossa JF, Kluge P, Schmiedel D, Kuball J, Dolstra H, Minguet S, Cornu TI, Cathomen T, Alici E, O'Dwyer M, Wels WS, Malmberg KJ, Romee R, Vivier E, Köhl U, Cerwenka A, Ullrich E (2026)
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective
Hum Gene Ther, 37 (15-16), 691-701
DOI 10.1177/10430342261468974, PubMed 42544553

Ning JF, Davis ZB, Zeb Q, Hinderlie P, Tuininga K, Wang L, Chaudhary S, Vue Y, Ma J, Zhu S, Zhang Y, Seeman ZJ, Malmberg KJ, Valamehr B, Largaespada DA, Zorko N, Felices M, Cichocki F, Miller JS, Chen CC (2026)
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Neuro Oncol (in press)
DOI 10.1093/neuonc/noag154, PubMed 42434963

Duléry R, Malmberg KJ, Romee R (2026)
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular Therapy
Blood Cancer Discov, OF1-OF4 (in press)
DOI 10.1158/2643-3230.BCD-26-0086, PubMed 41996826